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Background: Palliative cancer patients experience a complex clinical picture. Research
shows little correlation between nurses’ impressions of the patient’s symptoms and the
patient’s experience of their own symptoms. National guidelines recommend the use of
screening tools to chart and evaluate the patient’s symptoms systematically.
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Objective: The objective of the study is to elucidate palliative cancer patients’ self-
reporting of symptoms on admission to and discharge from a palliative care unit.
Method: The study was conducted at the Palliative Care Unit, University Hospital North
Norway, Harstad, in the period 2008–2016. The study uses data from the Edmonton
Symptom Assessment System (ESAS). The dataset is presented using descriptive
statistics.  
Results: The study comprised 274 patients, of whom 135 were women and 139 men.
Fatigue, dry mouth and loss of appetite emerge as the most distressing symptoms. Women
exhibited a greater symptom burden than men, with the exception of shortness of breath.
There was a significant reduction in all symptoms on discharge.
Conclusion: Good palliative care entails that nurses are attentive to and have knowledge
of the patients’ symptoms. Systematic registration of symptom data facilitates the
detection of symptoms that might otherwise have been overlooked. Early screening and
treatment may reduce the risk of major, problematic symptoms over a lengthy period, and
therefore give improved quality of life.
Palliative or supportive care is a new area of expertise
in both the Norwegian and the international context.
Cecily Saunders (1918–2005), who worked at St.
Christopher’s Hospice in London (1), established
modern palliation in the 1960s. Throughout the 1990s,
palliation received more attention in Norway, partly as
a result of the establishment of the Norwegian
Association for Palliative Medicine (2).
In 2007, the Norwegian Directorate for Health and
Social Affairs issued for the first time a national action
programme with guidelines for palliation in cancer
care (3). A new Official Norwegian Report on
palliative care was issued in 2017: På liv og død (A
matter of life or death) (1), which reviewed and
revised existing palliative care programmes and set out
parameters for future programmes.
Many patients in the palliative phase have both
physical and mental problems, and often present a
complex picture that can vary over time. Good
knowledge of the symptoms of this patient group is a
prerequisite for optimal care of the patient.
•
International research has shown that there is little
correlation between nurses’ impressions of the
patient’s symptoms and the patient’s actual clinical
picture (4). Nurses’ knowledge of the patient’s clinical
picture can be improved by using systematic screening
tools, particularly if the information acquired from
using such tools is included in nursing documentation
(5).
There is a clear correlation between a high symptom
score on the Edmonton Symptom Assessment System
(ESAS) and the implementation of clinical actions (6).
A number of international studies have presented
statistical data from ESAS (6–9). One of the main
goals of palliative care is to give higher quality of life
through better control of symptoms.
Myhra (2010) points to a need to conduct further
research on ESAS in which respondents are included,
at all of Norway’s palliative care units (10). Earlier
research has described different clinical pictures,
depending on gender, for various forms of cancer at
different stages. On the other hand, there is a lack of
information on gender-specific differences in respect
of palliative cancer patients (11, 12).
The national action programme for palliative cancer
care (13) provides guidelines for treatment,
competence and the organisation of palliative services
in Norway. These guidelines formed the framework
used when the palliative care unit at the University
Hospital North Norway, Harstad (UNN Harstad) was
established in 2008.
The objective of the study was to identify:
Earlier research
«Nurses’ knowledge of the patient’s clinical picture
can be improved by using systematic screening
tools.»




how palliative cancer patients report their
symptoms on initial admission to the palliative care
unit at UNN Harstad;
whether male and female cancer patients report a
different clinical picture; and
how patients’ experience of symptoms changes
during their initial stay at a palliative care unit.
When the palliative care unit at UNN Harstad was
established in 2008, it was the first palliative ward in
the Northern Norway Regional Health Authority. The
unit is open five days a week from Monday to Friday
as a palliative centre with three to four beds and an
outpatient clinic. It offers supervision and guidance to
the primary health service as well as home visits. Over
90 per cent of the unit’s patients have a cancer
diagnosis.
The study is designed as a retrospective, quantitative
study using anonymised data from the quality database
at the Palliative Care Unit, UNN Harstad. The
theoretical perspective is palliative nursing.
The Edmonton Symptom Assessment System (ESAS)
is a validated (8, 9, 14) and internationally recognised
self-reporting tool for systematic registration of
symptoms by patients receiving palliative care (15).
The screening tool was devised in Canada (15) and is
used both nationally and internationally.
Systematic use of ESAS is one of the quality
measurements in palliative care (1, 2). The tool exists
in several versions and has been translated to a number
of languages. The Norwegian version uses a numerical
scale from 0–10, where 0 represents ‘no symptoms’
and 10 represents ‘worst possible symptoms’.
Method
Palliative Care Unit - UNN Harstad
Design
ESAS
ESAS is used to chart pain when resting, pain when
active, fatigue, nausea, shortness of breath, dry mouth,
appetite, feeling anxious or nervous, and sadness or
depression. In addition, it includes a more general
question: ‘Overall, how do you feel today?’ The ESAS
form used in this study also charts constipation, in line
with recommendations from earlier research (10, 15–
17).
The patients’ symptoms are charted on a daily basis
using ESAS. On first admission to the unit, the patient
completes the form together with a nurse to avoid
misunderstandings. Afterwards, if the patient so
wishes, he/she can complete it on their own. The
conversation between the patient and the nurse or
doctor in this process is important and valuable, but is
not discussed further in this article.
In 2010, a revised version of the form was launched:
ESAS-R (18). In this study, we have used a traditional
ESAS form.
The International Statistical Classification of Diseases
and Related Health Problems, ICD-10, was used to
classify cancer diagnoses (19).
We employed the following inclusion criteria: 1) The
patient must have a cancer diagnosis on initial




Patient data are directly registered in IBM SPSS
(Statistical Package for the Social Sciences). We used
IBM SPSS version 22–23 and Microsoft Excel Version
2010 for the statistical analyses. Excel was used to
select the week’s first and last symptom score as well
as to prepare statistical figures. We used descriptive
statistics to present the dataset. The Shapiro-Wilk and
Kolmogorov-Smirnov tests demonstrated a skewed
distribution.
Based on earlier research (6, 20, 21), we categorised
the ESAS symptoms into four categories: ‘No
symptoms’, ‘Mild symptoms’, ‘Moderate symptoms’,
and ‘Pronounced symptoms’ (Figure 2). The Mann-
Whitney U test was used to test differences between
genders (Figure 3). We omitted gender-specific
diagnoses such as breast cancer, gynaecological
cancers and prostate cancer.
Statistical analyses
We used McNemar’s test to examine whether there
were significant differences in the clinical picture
between the first and last charting of symptoms
(Figure 4). Only patients screened using ESAS both on
admission and discharge were included in this specific
analysis. Data were dichotomised, and the scores 0, 1
and 2 were compared against the scores 3–10. The
goal is that the patient will score the symptom as 0–2.
In the case of pain when resting, the goal is defined as
NRS (Numeric Rating Scale) ≤3 in the Standard for
Palliative Care (2). We used the same categorisation as
for the other symptoms. This corresponds with the
goal that daily clinical practice attempts to achieve.
The significance level was set at 0.05. We carried out a
Bonferroni correction to reduce the risk of Type 1
errors.
The material we used in this project consists of
anonymised data from the quality database at the
Palliative Care Unit, UNN Harstad. The study was
subject to administrative processing by the Norwegian
Social Science Data Services (NSD), now the
Norwegian Centre for Research Data, via the data
protection officer at UNN.
The Regional Committee for Medical and Health
Research Ethics (REC North) has determined that the
database is not subject to the Health Research Act and
therefore does not require further approval (reference
number 2015/1661/REC North). We collected all data
as a routine part of patient treatment and the study has
therefore not entailed any kind of extra strain on the
informants.
Ethics
To ensure full anonymity, we omitted the patients’ ID
numbers when extracting data from the quality
database. The sequence of observation units was
randomised and the different diagnoses were combined
in ten large groups, none of which had less than five
patients (Table 1).
The study presented symptom data from 274 cancer
patients, of whom 135 were women and 139 were
men. The average age was 69.5 years with a
distribution from 38 to 90 years. Average survival after
first admission was 24 weeks. Data collection took
place in the period from 2008 to 2016. The number of
patients who charted the various symptoms is shown in
Figures 2, 3 and 4.
Results
Clinical picture on admission
In Figure 2, we present the symptoms dichotomised
into the following categories: ‘None’ (score 0), ‘Mild’
(score 1–3), ‘Moderate’ (score 4–6) and ‘Pronounced’
(score 7–10). Fatigue, dry mouth, loss of appetite and
sense of well-being (‘Overall, how do you feel
today?’) are symptoms which more than 50 per cent of
the patients rated as between 4 and 10. We find the
largest number of ‘pronounced symptoms’ for loss of
appetite (score 7–10).
Figure 3 presents the mean symptom burden stratified
for men and women. We have omitted patients with
breast cancer, gynaecological cancers and prostate
cancer.
With the exception of shortness of breath, women
report higher values than men for the symptoms
charted. However, the differences are only statistically
significant for the symptoms fatigue (p = 0.009) and
dry mouth (p = 0.005).
Clinical picture for women and men
The average length of stay at the unit was 3.3 days (SD
0.93), with 4 days constituting a whole week. Figure 4
shows a reduction in all symptoms after a stay at the
palliative care unit. McNemar’s test shows that the
change is statistically significant for all the symptoms
screened.
Status on admission and discharge
The health and care services are being evaluated and
assessed in respect of waiting time, use of resources
and time taken to receive the discharge report. There
are few quality indicators that provide information
about the quality of palliative care and follow-up
received by our most seriously ill patients in palliative
care (1). Recommendations were made as early as
2004 on identifying the proportion of patients screened
by ESAS as well as the proportion who achieved
satisfactory symptom relief (2).
The 2018 Official Norwegian Report on palliation also
highlighted ESAS as an effective screening tool (1).
National studies show that a systematic approach to
the patient using ESAS to provide targeted charting of
symptoms provides better information about patients’
problems and enhances nursing quality (16). Rhondali
et al. have shown that there is little correlation between
the patient’s symptoms and nurses’ impressions of
these symptoms (4).
Research that identifies correlations between various
symptoms shows that pain is often associated with
fatigue, nausea, tiredness and loss of appetite (11). The
findings in our study are of interest because the
secondary effects of pain seem to be more pronounced
than the pain itself. In contrast to pain, these symptoms
can be difficult to pinpoint, treat and evaluate without




«The findings in our study are of interest because the
secondary effects of pain seem to be more
pronounced than the pain itself.»
Charting symptoms is of central importance in a
palliative disease course in order to give the patient
optimal and effective relief for the troublesome
symptoms. The aim of charting symptoms, follow-up
treatment and evaluation is to achieve the best possible
quality of life. Symptoms that patients describe as
moderate to pronounced (4–10 on ESAS) should be
prioritised in patient treatment.
Loss of appetite and cachexia constitute a common
problem for palliative patients (22). In our study, 72
per cent of patients have a symptom score of >3 on
this question on admission (Figure 2). There may be
many causes such as oral fungal infections, changes in
sense of taste, difficulties swallowing, obstructions in
the GI tract, side effects of radiation therapy or
cytostatic treatment, accumulation of fluid in the
abdominal cavity (ascites), pain etc. (22).
Cachexia is a negative prognostic factor that is often
associated with a shorter life expectancy (22). Loss of
appetite alone or together with other symptoms
increases the nutritional risk for the patients. In
everyday clinical practice, it may be difficult for
nurses to identify whether a patient is facing a
nutritional risk before significant weight loss is
observable (22).
National recommendations stipulate that inpatients in
the specialist health service must be nutritionally
screened on admission using a validated tool, and
should then be monitored on a weekly basis. Measures
must be implemented, documented, evaluated and
reported to the next treatment level (23).
Poor nutrition increases the symptom burden and
reduces quality of life. Early intervention in the form
of dietary recommendations and nutritional
supplements is therefore crucial, particularly for this
patient group (22).
Loss of appetite
In our study, 69 per cent of patients rate fatigue at an
intensity of >3 on admission (Figure 2). Cancer-related
fatigue is estimated to affect 90 per cent of the patients
(21). The intensity increases during the cancer
trajectory (21).
Fatigue is a considerable challenge in cancer care and
is often overlooked and therefore inadequately treated
(21). The causes of fatigue are complex, and nutrition,
pain, side effects of tumour-related treatment and
anxiety are important contributory factors. It is
therefore vital that nurses have knowledge of the
phenomenon.
A dry mouth (xerostomia) is indicated as a problem for
over half of the patients with advanced cancer (24). In
our study, 53 per cent rate dry mouth at an intensity of
>3 on ESAS. A dry mouth is often due to a
combination of different medications, chemotherapy
and radiotherapy, and results more readily in infections
in the oral cavity. In addition, seriously ill patients
experience a decline of the immune system, making
them more vulnerable to oral infections (25).
It is vital that nurses pay attention to oral health. Focus
on this issue and early implementation of
recommended measures may prevent and relieve
symptoms. There is a range of measures that can ease a
dry mouth, such as good oral hygiene, the use of
lozenges or a spray to stimulate saliva secretion, and
avoiding sweet foods in addition to frequently drinking
copious amounts of water. Medication can also relieve




Constipation is reported as a considerable problem for
palliative patients (10, 15–17). Nevertheless, only 26
per cent of patients in this study score this at >3. Other
studies have revealed that constipation occurs in 50–
60 per cent of patients with advanced cancer, and in up
to 90 per cent of patients who use opioids (13).
Constipation is often accompanied by a distended
abdomen, pain, loss of appetite, nausea, vomiting,
headache, restlessness and obstipation diarrhoea (13),
and can thus have a considerable negative effect on
quality of life. Several publications have emphasised
that constipation should be included in ESAS (10, 15,
16), which may have been a contributing factor in its
inclusion in ESAS-R.
The low prevalence of constipation problems in the
study can partly be explained by good prevention
measures at the referral wards. Early referral to the
palliative care unit during the disease course may also
be a contributory cause.
In answer to the question ‘Overall, how do you feel
today?’ 53 per cent of the patients give a score of >3
on ESAS. Successful palliative care demands the
capacity to interpret the patient’s clinical picture as
well as the ability and willingness to alter palliative
measures as the disease changes (24).
Clinical experience of using ESAS has shown that the
question of well-being can be difficult to answer
because the question is seen as fairly vague. Many
patients answer this question by saying ‘not too good
and not too bad’. Bergh et al. found the same in a 2010
study (26).
Well-being
The degree of accuracy in answers to this question
depends on the nurse taking the time to have a
conversation about how the patient feels. It is in
conversations about everyday topics that important
issues can emerge.
Such a conversation is exemplified by a nurse’s
dialogue with a patient with advanced cancer who was
in the middle of a house renovation. During the
conversation, the patient produced a colour chart and
asked the nurse: ‘Do you think I would be happy with
this colour in my kitchen?’
The question related of course to the choice of colour
but it was equally a desire for confirmation that the
patient would live to see the newly painted kitchen.
Use of ESAS is often a starting point for good
conversations about existential questions, questions
that go far beyond the charting of symptoms.
The study shows that women, with the exception of
those experiencing shortness of breath, present a
greater symptom burden on average than men. The
differences are statistically significant in the case of
fatigue and dry mouth. In a 2011 study, Culleton et al.
found no significant differences in the clinical picture
for men and women when gender-specific diagnosis
groups were excluded (27).
Earlier research has shown that women experience
more opioid-based side effects than men (28).
Nevertheless, it is uncertain if the differences in our
dataset can be explained by gender-based differences
in the metabolisation of opioids. Several studies have
discussed fatigue or tiredness in cancer patients in
relation to gender-based differences (12, 27, 29).
Gender differences
«The study shows that women, with the exception of
those experiencing shortness of breath, present a
greater symptom burden on average than men.»
Our study does not provide an explanation of gender
differences in respect of cancer symptoms.
Nevertheless, it highlights the importance of focussing
on and maintaining an awareness of how patients may
experience different symptoms depending on gender.
The study shows a significant decline in all symptoms
in both men and women on discharge from our
palliative care unit. This is the case regardless of the
short duration of hospitalisation and despite the fact
that the unit is a five-day ward with an average
hospitalisation period of 3.34 days (a whole week = 4
days).
The factors that may explain the improvement in
symptoms are that the patients come for planned
hospitalisation and assessment. Treatment measures
have often been decided prior to admission and these
can be implemented immediately after charting the
symptoms upon admission. Systematic, repeated
measurements of symptoms are crucial to safeguarding
accurate and targeted treatment measures.
The use of a validated assessment tool such as ESAS
gives nurses and doctors precise measurements of the
patient’s symptom burden. Repeated measurements
using ESAS are effective because the patients
themselves become the key to healthcare personnel
accurately evaluating symptoms.
The effect of a stay at the Palliative Care Unit - UNN
Harstad
«Systematic, repeated measurements of symptoms
are crucial to safeguarding accurate and targeted
treatment measures.»
The study’s limitations and sources of error
The study presents the symptom burden of palliative
cancer patients at UNN Harstad on their initial
admission to the palliative care unit. Our study only
monitored patients for a few days and contains no
information about the impact of symptom relief on
prognosis, life expectancy and quality of life. In order
to answer the research questions, we used only ESAS
as a screening tool, which naturally constituted a
limitation.
Although spiritual and existential needs in addition to
the perspectives of the patient’s family are a natural
part of holistic, palliative care, our study does not
discuss these. The patients in the study included both
men and women with different cancer diagnoses and
of different ages. Any generalisation of the findings
must therefore be made with caution since the patient
data are limited.
Many patients said it was difficult to rate a symptom.
Some symptoms, such as ‘dry mouth’ and ‘Overall,
how do you feel today?’ were described as particularly
difficult to define on a numerical scale.
Norwegian research from 2011 revealed a risk that
patients may misunderstand ESAS and wrongly
interpret the questions. It is therefore necessary to go
over the form together with the patient (26), as we did
systematically in our study. Eight to ten different
nurses, all of whom had received prior training in the
use of ESAS, collected the data.
The fact that different nurses helped patients to
complete ESAS may have led to variations in the
values submitted. The most seriously ill patients were
not included.
It is easy to give an inverse response for the ‘appetite’
symptom (good appetite should be ‘0’, no appetite
‘10’). A number of publications have pointed out this
phenomenon (26, 30). The personnel at the unit were
aware of this potential source of error and avoided
erroneous registration.
Proficient nursing entails attention to and knowledge
of patients’ symptoms. The study shows that
systematic registration of symptom data together with
swift implementation of palliative measures to relieve
symptoms leads to a diminished symptom burden.
Systematic use of ESAS increases the likelihood of
discovering symptoms that might otherwise be
overlooked.
Loss of appetite, dry mouth and fatigue are the
dominant challenges for cancer patients on initial
admission to the Palliative Care Unit - UNN Harstad.
In a palliative disease course, systematic charting of
symptoms, swift start-up of interdisciplinary treatment
measures and evaluation of these measures are
prerequisites for effective treatment.
The study shows that systematic use of ESAS with
rapid implementation of treatment measures gives a
reduction in all symptoms charted despite short
hospitalisation. Finally, we would emphasise that
ESAS cannot replace a proper conversation but is a
useful tool for more targeted treatment of symptoms.
One of the main goals of a stay at a palliative care unit
is to relieve the patient’s symptoms. This study
presents a picture of how palliative patients report their
symptoms. The study can be used in future qualitative
and quantitative research to underpin how cancer
patients in the palliative stage rank their symptoms.
Conclusion
Recommendations for further research
The study also confirms the need for treatment
programmes offering expertise in palliation in Norway.
It is important to direct focus to cancer patients’
symptoms. Cancer symptoms are complex and
challenging for patients, their families, and health
personnel.
The results of this study can have clinical implications
for the nursing of palliative patients. For example,
further research could focus on the impact of specific
nursing measures in respect of symptom relief and
improved quality of life.
The study has not received external funding, and the
authors report no conflicts of interest.
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